Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 12 of 12 for “"UGT1A9"”.

  1. UDP-Glucuronosyltransferase (UGT) Genetic Variants and their Potential Role in Carcinogenesis

    … for cancer. Three UDP-glucuronosyltransferases, UGT1A9, UGT1A10, and UGT2B7, have been shown to play an important role in the phase II metabolism of carcinogenic metabolites of BaP. Because UGT1A9 and UGT2B7 are well-expressed in digestive tract tissues including liver and colon, it is possible …

    usf Repository record for UDP-Glucuronosyltransferase (UGT) Genetic Variants and their Potential Role in Carcinogenesis (opens in a new tab)

  2. Mechanisms of Interplay between UGTs and Efflux Transporters in Flavonoid Disposition

    … the simplest interplay between one UGT (i.e., UGT1A9) and an efflux transporter (i.e., BCRP); 2) study the interplay between UGT1A9 and BCRP in flavonoid disposition using the established and well-characterized HeLa cell model; 3) compare the interplay between UGTs and efflux transporters in …

    houston Repository record for Mechanisms of Interplay between UGTs and Efflux Transporters in Flavonoid Disposition (opens in a new tab)

  3. Experimental and Computational Approaches to Predict Glucuronidation of Phenolics

    … regioselectivity (b); 2) to determine the UGT1A9-mediated glucuronidation parameters for selected flavonols (n=30) and establish a pharmacophore-based in silico model using this dataset; 3) to determine UGT1A9-mediated glucuronidation parameters for a large class of structurally diverse …

    houston Repository record for Experimental and Computational Approaches to Predict Glucuronidation of Phenolics (opens in a new tab)

  4. Relationship Between Flavonoid Structure And Phase-II Metabolism

    … the in silico prediction models for UGT 1A8 and UGT1A9 using pharmacophore and 2-D/3-D QSAR modeling techniques; 4) study the effect of change in backbone on the disposition of flavonoids in Caco-2 cells; 5) study the rate-limiting role of efflux transporters in the disposition of flavonols in …

    houston Repository record for Relationship Between Flavonoid Structure And Phase-II Metabolism (opens in a new tab)

  5. Acquired resistance to HSP90 inhibition in triple-negative breast cancer

    … We demonstrate that upregulated expression of UGT1A9, possibly due to an increased intrinsic oxidative stress, is associated with acquired resistance to resorcinol-based HSP90i in TNBC cells, and sensitivity to HSP90i can be restored with a competitive inhibitor of UGT1A9. The HSP90i-resistant …

    oxford Repository record for Acquired resistance to HSP90 inhibition in triple-negative breast cancer (opens in a new tab)

  6. Human host and malaria parasite genome variations to susceptibility to malaria

    … specific pharmacogenes variants showed that UGT1A9 had the highest proportion of variants (> 80%) in the malaria endemic populations. The ABC drug transporters such as ABCC4, ABCC1 and ABCC2 were found to have a higher proportion of pathogenic SNPs in populations of the four malaria endemic …

    cape-town Repository record for Human host and malaria parasite genome variations to susceptibility to malaria (opens in a new tab)

  7. Investigations on the phase II metabolism of propranolol and hydroxypropranolols

    … of CYP2D6 activity by UGT1A7, UGT1A8, and UGT1A9, while UGT2A1 has no influence. Conversely, CYP2D6 suppresses the glucuronidation process catalyzed by the four UGTs. Notably, this study unveils a functional interaction between CYP2D6 and UGT1A subfamilies in drug metabolism, providing …

    fu-berlin Repository record for Investigations on the phase II metabolism of propranolol and hydroxypropranolols (opens in a new tab)

  8. The Role of Breast Cancer Resistance Protein (BCRP) in Disposition of Glucuronide Conjugates

    … efflux transporters. [Methods] Human UGT1A9-overexpressing HeLa cells and MRP2-overexpressing MDCKII-UGT1A1 cells were used as in vitro cellular models to study the excretion of glucuronides by BCRP and MRP2, respectively. Pooled intestinal and hepatic S9 fractions were used to …

    houston Repository record for The Role of Breast Cancer Resistance Protein (BCRP) in Disposition of Glucuronide Conjugates (opens in a new tab)

  9. The ontogeny of hepatic detoxification in children: implications for pediatric non-alcoholic fatty liver disease

    … post-translationally and/or allosterically while UGT1A9 matures mostly due to transcriptional effects. When scaled to whole liver, hepatic clearances matured later, from one to eighteen years of age. Furthermore, the age of maturation varied between the four clearance models (well-stirred and …

    hawaii Repository record for The ontogeny of hepatic detoxification in children: implications for pediatric non-alcoholic fatty liver disease (opens in a new tab)

  10. IDENTIFICATION OF CLINICAL, LABORATORY AND GENETIC COVARIATES FOR PHARMACOKINETICS, EFFICACY AND TOXICITY OF SORAFENIB IN PATIENTS WITH SOLID TUMORS

    … pharmacokinetic analysis, while BSA, albumin and UGT1A9*3 appeared to be significant by NCA-GLM. However, the contribution of these covariates in overall exposure variability was very small; hence, these were considered clinically irrelevant. The association of sorafenib exposure with efficacy in …

    vcu Repository record for IDENTIFICATION OF CLINICAL, LABORATORY AND GENETIC COVARIATES FOR PHARMACOKINETICS, EFFICACY AND TOXICITY OF SORAFENIB IN PATIENTS WITH SOLID TUMORS (opens in a new tab)

  11. A Pharmacometrics Approach to Understanding Drug Disposition and Drug Interactions in Healthy Individuals and Patients Undergoing Roux-en-Y Gastric Bypass

    … a decline in the activities of CYP2E1, UGT1A1, UGT1A9, and SULT1A1 following RYGBS. As drug-drug interaction (DDI) studies have not been conducted in patients undergoing RYGBS, we used an in silico approach to predict DDIs in this patient population (Chapter 3). Using physiologically-based …

    washington Repository record for A Pharmacometrics Approach to Understanding Drug Disposition and Drug Interactions in Healthy Individuals and Patients Undergoing Roux-en-Y Gastric Bypass (opens in a new tab)

  12. Pediatric Physiologically Based Pharmacokinetic (PBPK) Modeling to Advance Knowledge of Breastfeeding Infant Exposure to Maternal Medications

    … contributions were ascertained as UGT1A7 4%, UGT1A9 16%, UGT2B7 10%, CYP3A4 38%, CYP2C19 21%, and CYP2C9 11%. This information was used to populate the CBD pediatric PBPK model. Results from the linear regression analysis with maternal factors, including administration type, dose-frequency of …

    waterloo Repository record for Pediatric Physiologically Based Pharmacokinetic (PBPK) Modeling to Advance Knowledge of Breastfeeding Infant Exposure to Maternal Medications (opens in a new tab)